Stanley Druckenmiller Teva Pharmaceutical Industries LTD Transaction History
Duquesne Family Office LLC
- $3.06 Billion
- Q1 2025
A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Duquesne Family Office LLC holds 14,879,750 shares of TEVA stock, worth $252 Million. This represents 7.47% of its overall portfolio holdings.
Number of Shares
14,879,750
Previous 8,997,400
65.38%
Holding current value
$252 Million
Previous $198 Million
15.33%
% of portfolio
7.47%
Previous 5.33%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
627MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$729 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$662 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$641 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$495 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$472 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...